Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Formoterol, Beclometason, Glycopyrronium, F. D. Z. 01.11.25 - 31.10.26 (plus Extension Option 1x12 Mon) 2026-03-17
Germany Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Iron (parenteral Preparations), Atc B03ac07 F. D. Z. 01.11.25-31.10.27 (plus Extension Option 1x12 Month) 2026-03-17
Germany Medicines With The Active Ingredient Infliximab (atc: L04ab02 - In The Dosage Form Injection Solution) 2026-03-17
Germany Finallynot Excl.according To Section 130a (8) Sgb V By Means Of An Oh-mod.to The Active Ingredient In The Be-clometason/formoterol (atc Code According To Who: R03ak08), Out. The Acting. 100µg/6µg As Dosingaerosol 2026-03-17
Germany Medicines With The Active Ingredient Infliximab (atc: L04ab02 - In The Dosage Form Powder For The Here. Of An Infusion Solution Concentrate Or Powder For A Concentrate On The Here. 2026-03-17
Germany Medicines Containing The Active Substance Infliximab (atc) 2026-03-17
Germany Conclusion Of A Non-exclusive Drug Discount Agreement Pursuant To Section 130a, Paragraph 8 Of The German Social Code (sgb V) Through An Open-house Model For The Active Ingredient Sodium Oxybate (who Atc Code: N07xx04) 2026-03-17
Germany Not Except Am-rabattvereinb. According To § 130a Abs. 8 Sgb V By Means Of An Oh-mod. To The Active Substance Beclometason/formoterol (atc Code According To Who: R03ak08), Except The Active St. 100µg/6µg As Dosiererosol 2026-03-17
India _14628 Market Of Supplies For The Purchase, Installation And Maintenance Of Medical Equipment In The Democratic Republic Of Congo 2026-03-17
Germany Finally Not Excl. According To Section 130a (8) Sgb V By Means Of An Oh-mod. To The Active Ingredient In The Be-clometason/formoterol (atc Code According To Who: R03ak08), Out. The Acting. 100µg/6µg As Dosingaerosol 2026-03-17
Whats app